Plexus Corp. said Monday that John Nussbaum, co-founder of the manufacturing company and its non-executive chairman, will retire from its board in February.Plexus has appointed Dean Foate, its ...

SAN DIEGO, March 10, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025 ...

DexCom, Inc.: Steven R. Pacelli Executive Vice President, Strategy and Corporate Development (858) 200-0200 www.dexcom.com Release Summary Dexcom Appoints Kyle Malady to Board of Directors ...

NEENAH, WI - Plexus Corp (NASDAQ:PLXS), a leading provider of printed circuit boards with a market capitalization of $3.77 billion, announced the results of its 2025 Annual Meeting of Shareholders ...

It was reported on November 13, that Dean A Foate, Board Member at Plexus (NASDAQ:PLXS) executed a significant insider sell, according to an SEC filing.What Happened: According to a Form 4 filing ...

SAN DIEGO, March 10, 2025--Dexcom Appoints Renée Galá to Board of Directors. SAN ... a global biopharmaceutical company with greater than $4 billion in total revenues in 2024 whose purpose is to ...

DexCom, Inc., the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025. She currently serves as President and ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025. Ms. Galá is an ...